Abbvie Inc at SVB Leerink Global Healthcare Conference (Virtual) Transcript

Feb 26, 2021 / 03:40PM GMT
Geoffrey Craig Porges - SVB Leerink LLC, Research Division - Director of Therapeutics Research & Diversified Biopharma and Senior Research Analyst

Good morning, everybody. Welcome to our next session at our Global Healthcare Virtual conference. I'm delighted to welcome AbbVie to the GHC this year. AbbVie is represented by Mike Severino, Vice Chairman and President; Rob Michael, EVP and Chief Financial Officer; and Jeff Stewart, EVP of Commercial Operations. Liz Shea will be standing by to keep us all within bounds. So thank you all for joining us this morning.

Michael E. Severino - AbbVie Inc. - Vice Chairman & President

It's a pleasure to be here. Good to see you, Geoff.

Questions and Answers:

Geoffrey Craig Porges - SVB Leerink LLC, Research Division - Director of Therapeutics Research & Diversified Biopharma and Senior Research Analyst

So Mike, perhaps the most pressing question that I hear from investors is about RINVOQ and safety and all that sort of thing. So perhaps you could give us your
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot